Web Chapter 1 Any alteration in acid-base equilibrium sets into motion a compensatory response by either the lungs or the kidneys. The compensatory response attempts to return the ratio between PCO2 and to normal and thereby minimize the pH change. A primary increase or decrease in one component is associated with a predictable compensatory change in the same direction in the other component (Web Table 1-1). Adaptive changes in plasma in respiratory disorders occur in two phases: acute and chronic. In respiratory acidosis, the first phase represents titration of nonbicarbonate buffers, whereas in respiratory alkalosis, the first phase represents release of H+ from nonbicarbonate buffers within cells. This response is completed within 15 minutes. The second phase reflects renal adaptation and consists of increased net acid excretion and increased reabsorption (decreased Cl− reabsorption) in respiratory acidosis and decreased net acid excretion in respiratory alkalosis. Adaptive respiratory response to metabolic disorders begins immediately and is complete within hours. Some guidelines for use of compensatory rules from Web Table 1-1 are presented in Web Box 1-1. WEB TABLE 1-1 Compensatory Response in Simple Acid-Base Disturbances in Dogs and Cats Modified from de Morais HSA, DiBartola SP: Ventilatory and metabolic compensation in dogs with acid-base disorders, J Vet Emerg Crit Care 1(2):39, 1991; and de Morais HSA, Leisewitz A: Mixed acid-base disorders. In DiBartola SP, editor: Fluid, electrolyte, and acid-base disorders, ed 3, Philadelphia, 2006, Elsevier, p 296. Calculating the various gaps and gradients can be useful in evaluation of acid-base disorders (Web Box 1-2). Increases in the anion gap (AG) and strong ion gap (SIG) are associated with increases in concentration of unmeasured anions, both strong (e.g., lactate, acetoacetate, β-hydroxybutyrate, strong anions of renal failure) and weak (e.g., phosphate). The AG also is used to differentiate between hyperchloremic (normal AG) and high-AG metabolic acidoses. The AG in normal dogs and cats is mostly a result of the net negative charge of proteins and thus is heavily influenced by protein concentration, especially albumin. At plasma pH of 7.4 in dogs, each decrease of 1 g/dl in albumin concentration is associated with a decrease of 4.1 mEq/L in the AG (Constable and Stämpfli, 2005). The SIG is not affected by changes in albumin concentration, and an increase in unmeasured strong anions is suspected whenever SIG is less than −5 mEq/L. The SIG has not been clinically tested in dogs and cats, but its derivation is sound, and it is superior to the AG for detecting increases in unmeasured strong anions in other species. Frequently, patients with respiratory acidosis or alkalosis also are hypoxemic. When determining management options, it is important to differentiate between hypoxia from primary lung disease (e.g., ventilation-perfusion mismatching) and alveolar hypoventilation by calculating the alveolar-arterial oxygen gradient, or (A – a) O2 gradient. Values less than 15 mm Hg generally are considered normal. If the (A − a) O2 gradient is increased, a component of the hypoxemia results from ventilation-perfusion mismatching, although it may be increased in some patients with extrapulmonary disorders. Clinically, a normal gradient excludes pulmonary disease and suggests some form of central alveolar hypoventilation or an abnormality of the chest wall or inspiratory muscles. To increase the specificity of the test to diagnose ventilation-perfusion mismatch, only patients with (A − a) O2 gradient values of more than 25 mm Hg should be considered abnormal (Johnson and de Morais, 2012). These patients are likely to have primary pulmonary disease, but extrapulmonary disorders cannot be completely ruled out. Respiratory alkalosis, or primary hypocapnia, is characterized by decreased PCO2, increased pH, and a compensatory decrease in concentration in the blood. Respiratory alkalosis occurs whenever the magnitude of alveolar ventilation exceeds that required to eliminate the CO2 produced by metabolic processes in the tissues. Common causes of respiratory alkalosis include stimulation of peripheral chemoreceptors by hypoxemia, primary pulmonary disease, direct activation of the brainstem respiratory centers, overzealous mechanical ventilation, and situations that cause pain, anxiety, or fear (Web Box 1-3). It is difficult to attribute specific clinical signs to respiratory alkalosis in the dog and cat. The clinical signs usually are caused by the underlying disease process and not by the respiratory alkalosis itself. However, in humans, headache, light-headedness, confusion, paresthesias of the extremities, tightness of the chest, and numbness around the mouth have been reported in acute respiratory alkalosis. If the pH exceeds 7.6 in respiratory alkalosis, neurologic, cardiopulmonary, and metabolic consequences may arise. Such a pH only can be achieved in acute respiratory alkalosis before renal compensation ensues. Alkalemia results in arteriolar vasoconstriction that can decrease cerebral and myocardial perfusion. In addition, hyperventilation (PCO2 < 25 mm Hg) causes decreased cerebral blood flow, potentially resulting in clinical signs such as confusion and seizures. Treatment of respiratory alkalosis should be directed at relieving the underlying cause of the hypocapnia; no other treatment is effective. Respiratory alkalosis severe enough to cause clinical consequences for the animal is uncommon. Hypocapnia itself is not a major threat to the well-being of the patient. Thus the underlying disease responsible for hypocapnia should receive primary therapeutic attention.
Acid-Base Disorders
Stepwise Approach
Calculate the Expected Compensation
Calculate Gaps and Gradients
Strong Ion Gap and Anion Gap
Alveolar-Arterial Oxygen Gradient
Respiratory Acid-Base Disorders
Disorders of PCO2
Respiratory Alkalosis